- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05957835
The Effect of Beetroot Juice Supplementation Dose on Neuromuscular Performance During Resistance Exercise
July 16, 2023 updated by: Rachel Tan, Pepperdine University
Dietary nitrate supplementation, administered in the form of nitrate-rich beetroot juice, has been shown to improve exercise performance and may have more pronounced effects on exercise that requires high-power and high-velocity muscle contraction such as weightlifting and body-mass resisted exercise (i.e, resistance exercise).
However, limited data are available that have examined the potential performance enhancing effect of beetroot juice in resistance exercise.
Moreover, there is no information on the dose of nitrate required for performance enhancing effects during resistance exercise which limits its widespread use to enhance performance.
Therefore, the investigators will assess if supplementing the diet with nitrate-rich beetroot juice impacts resistance exercise performance (e.g., power, velocity), when compared to supplementing the diet with nitrate-depleted beetroot juice (i.e.
placebo).
The investigators will also investigate the dose-response effect of beetroot juice on resistance exercise performance by providing a low, moderate, and high nitrate dose of concentrated beetroot juice.
The results of this study will improve understanding of whether beetroot juice influences resistance exercise performance and will provide insight on whether different doses of beetroot juice influence the efficacy of nitrate supplementation on resistance exercise performance.
Together, these data will guide supplementation strategies for enhancing resistance exercise performance.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Supplementation with inorganic nitrate, which is most commonly administered in the form of concentrated nitrate-rich beetroot juice shots, has emerged as an ergogenic nutritional strategy.
Beetroot juice ingestion has been reported to enhance endurance and high-intensity intermittent exercise performance in running and cycling.
These improvements are attributed to augmented muscle contractility, force production and blood flow distribution, specifically in muscle groups comprised predominantly of type II muscle fibers.
Together, such changes provide a strong physiological rationale supporting the potential for dietary nitrate to enhance high-power and high-velocity muscle contractions since type II muscle fibers are heavily activated during these tasks.
However, the influence of dietary nitrate on resistance exercise performance is substantially underdeveloped with most previous studies having assessed the effect of nitrate supplementation on running and cycling endurance and high-intensity intermittent exercise.
Moreover, there is no information on the dose of nitrate required to evoke ergogenic effects during resistance exercise, which greatly hinders the potential implementation of beetroot juice as a research-informed performance enhancing supplement for resistance exercise.
Thus, the proposed project will investigate if acute dietary nitrate ingestion, provided as nitrate-rich beetroot juice, elicits improvements in various neuromuscular performance parameters (e.g., power, velocity) during resistance exercise performance when compared to supplementing the diet with a nitrate-depleted beetroot juice placebo.
The investigators will also investigate the dose-response effect of beetroot juice on resistance exercise performance by providing low (70 ml i.e., ~6.5 mmol or ~400 mg of nitrate), moderate (140 ml i.e., ~13 mmol or ~800 mg of nitrate) and a high nitrate dose (280 ml i.e., ~26 mmol or ~1600 mg of nitrate) of concentrated beetroot juice.
This project will provide insight to practitioners (coaches/athletes) aiming to enhance performance in settings where muscular power and speed are key determinants for success, as well as to scientists exploring the efficacy of beetroot juice as a form of dietary nitrate supplementation to improve muscle contractile function.
Study Type
Interventional
Enrollment (Estimated)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Rachel Tan, PhD
- Phone Number: 3105067041
- Email: rachel.tan@pepperdine.edu
Study Contact Backup
- Name: Adam Pennell, PhD
- Phone Number: 3105064162
- Email: adam.pennell@pepperdine.edu
Study Locations
-
-
California
-
Malibu, California, United States, 90263
- Recruiting
- Pepperdine University
-
Contact:
- Rachel Tan, PhD
- Phone Number: 310-506-7041
- Email: rachel.tan@pepperdine.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Recreationally active males who performed resistance exercise at least twice weekly for the last two years
Exclusion Criteria:
- individuals with contraindications to exercise, cardiometabolic disease, currently consuming dietary supplements containing caffeine, sodium bicarbonate, creatine, beta-alanine, and/or NO precursor supplements (i.e., NO3-, arginine, citrulline, antioxidants), females, and smokers
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: BR-HIGH
Participants will ingest an elevated dose of nitrate 2.5 hours prior to exercise.
|
4 x nitrate-rich beetroot juice shots (26 mmol of nitrate)
|
|
Experimental: BR-MOD
Participants will ingest a moderate dose of nitrate 2.5 hours prior to exercise.
|
2 x nitrate-rich beetroot juice shots + 2 x nitrate-depleted beetroot juice shot (12 mmol of nitrate)
|
|
Experimental: BR-LOW
Participants will ingest a low dose of nitrate 2.5 hours prior to exercise.
|
1 x nitrate-rich beetroot juice shot + 3 x nitrate-depleted beetroot juice shots (6 mmol of nitrate)
|
|
Placebo Comparator: PL
Participants will ingest a negligible amount of nitrate 2.5 hours prior to exercise.
|
4 x nitrate-depleted beetroot juice shots (0 mmol of nitrate)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma nitrate
Time Frame: Through study completion, at least 1 year
|
Plasma nitrate concentrations in each condition from blood samples draw at rest prior to exercise, and analyzed using gas phase chemiluminescence
|
Through study completion, at least 1 year
|
|
Plasma nitrite
Time Frame: Through study completion, at least 1 year
|
Plasma nitrite concentrations in each condition from blood samples draw at rest prior to exercise, and analyzed using gas phase chemiluminescence
|
Through study completion, at least 1 year
|
|
Neuromuscular performance during countermovement jumps
Time Frame: Through study completion, at least 1 year
|
Peak force will be measured using a force place.
|
Through study completion, at least 1 year
|
|
Neuromuscular performance during countermovement jumps
Time Frame: Through study completion, at least 1 year
|
average propulsion force will be measured using a force place.
|
Through study completion, at least 1 year
|
|
Neuromuscular performance during countermovement jumps
Time Frame: Through study completion, at least 1 year
|
rate of power development will be measured using a force place.
|
Through study completion, at least 1 year
|
|
Neuromuscular performance during countermovement jumps
Time Frame: Through study completion, at least 1 year
|
peak positive power will be measured using a force place.
|
Through study completion, at least 1 year
|
|
Neuromuscular performance during countermovement jumps
Time Frame: Through study completion, at least 1 year
|
concentric mean power will be measured using a force place.
|
Through study completion, at least 1 year
|
|
Neuromuscular performance during countermovement jumps
Time Frame: Through study completion, at least 1 year
|
jump height will be measured using a force place.
|
Through study completion, at least 1 year
|
|
Neuromuscular performance during countermovement jumps
Time Frame: Through study completion, at least 1 year
|
takeoff velocity will be measured using a force place.
|
Through study completion, at least 1 year
|
|
Neuromuscular performance during countermovement jumps
Time Frame: Through study completion, at least 1 year
|
flight time will be measured using a force place.
|
Through study completion, at least 1 year
|
|
Neuromuscular performance during countermovement jumps
Time Frame: Through study completion, at least 1 year
|
Peak force, average propulsion force, rate of power development, peak positive power, concentric mean power, jump height, takeoff velocity, flight time will be measured using a force place.
|
Through study completion, at least 1 year
|
|
Peak power
Time Frame: Through study completion, at least 1 year
|
Power will be measured using a linear transducer with the highest value will be recorded for peak power
|
Through study completion, at least 1 year
|
|
Mean power
Time Frame: Through study completion, at least 1 year
|
Power will be measured using a linear transducer and will be averaged across sets for the determination of mean power
|
Through study completion, at least 1 year
|
|
Mean velocity
Time Frame: Through study completion, at least 1 year
|
Velocity will be measured using a linear transducer and will be averaged across sets for the determination of mean velocity
|
Through study completion, at least 1 year
|
|
Peak velocity
Time Frame: Through study completion, at least 1 year
|
Velocity will be measured using a linear transducer the highest value will be retained for peak velocity
|
Through study completion, at least 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mood
Time Frame: Through study completion, at least 1 year
|
24 items representing six subscales (i.e., anger, confusion, depression, fatigue, tension, vigour; four-items per subscale) will be captured using a five-point Likert scale (i.e., 0 = not at all, 1 = a little, 2 = moderately, 3 = quite a bit, 4 = extremely)
|
Through study completion, at least 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Rachel Tan, PhD, Pepperdine University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 23, 2023
Primary Completion (Estimated)
April 28, 2024
Study Completion (Estimated)
June 30, 2024
Study Registration Dates
First Submitted
June 28, 2023
First Submitted That Met QC Criteria
July 16, 2023
First Posted (Estimated)
July 24, 2023
Study Record Updates
Last Update Posted (Estimated)
July 24, 2023
Last Update Submitted That Met QC Criteria
July 16, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- RT12
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, upon request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on High Nitrate Dose
-
Northumbria UniversityCompletedLow Fat Meal - Unadjusted Insulin Dose | High Fat Meal - Unadjusted Insulin Dose | High Fat Meal - Adjusted Insulin Dose +30 Percent | High Fat Meal - Adjusted Insulin Dose +Split Dose
-
Ankara UniversityNot yet recruitingLow-Dose High-Frequency CPR Training
-
Hillel Yaffe Medical CenterCompletedHigh-dose Steroids, Myocardial Function, Longitudinal StrainIsrael
-
PfizerCompletedArthritis | Rheumatoid | High DoseJapan
-
University of GreenwichCrown Sport NutritionCompleted
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownChildren Treated With High-Dose Chemotherapy (HDC) Followed by Haematopoietic Stem Cell Transplantation (HSCT)France
-
Nanjing First Hospital, Nanjing Medical UniversityNot yet recruitingHelicobacter Pylori Infection | High-dose Dual Therapy | Metabolic-associated Steatohepatitis | Huazhi Rougan Granule
-
University of ReadingCompletedNitrate Vasodilator Adverse ReactionUnited Kingdom
-
Assiut UniversityUnknown
-
Second Affiliated Hospital, School of Medicine,...UnknownHigh-dose BiapenemChina
Clinical Trials on BR-HIGH
-
University of ThessalyCompletedBody Composition | Physical Fitness | Energy Expenditure | Resting Metabolic RateGreece
-
Henan Cancer HospitalNot yet recruiting
-
Boehringer IngelheimCompleted
-
Boryung Pharmaceutical Co., LtdCompletedHypertensionKorea, Republic of
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Boryung Pharmaceutical Co., LtdCovanceCompletedEssential Hypertension
-
Boehringer IngelheimCompleted
-
Fei LiNot yet recruiting
-
Boryung Pharmaceutical Co., LtdCompleted
-
Boryung Biopharma Co., Ltd.CompletedTetanus | DiphtheriaKorea, Republic of